tiprankstipranks
DBV Technologies S.A. - American Depositary Shares (DBVT)
NASDAQ:DBVT
US Market
DBVT
DBV Technologies SA - American
RESEARCH TOOLSreports
Want to see DBVT full AI Analyst Report?

DBV Technologies SA - American (DBVT) Stock News & Sentiment

451 Followers
DBV Technologies Maintained at Buy as Commercialization Prospects Grow; $40 Price Target Reaffirmed
Premium
Ratings
DBV Technologies Maintained at Buy as Commercialization Prospects Grow; $40 Price Target Reaffirmed
18d ago
DBVT
DBV Technologies: Differentiated Viaskin Peanut Profile and Solid Cash Runway Support Buy Rating
Premium
Ratings
DBV Technologies: Differentiated Viaskin Peanut Profile and Solid Cash Runway Support Buy Rating
29d ago
DBVT
DBV Technologies S.A. – American Depositary Shares (DBVT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
DBV Technologies S.A. – American Depositary Shares (DBVT) Q4 Earnings Cheat Sheet
3M ago
DBVT
DBV Technologies Highlights Positive Phase 3 Peanut Patch Data
Premium
Company Announcements
DBV Technologies Highlights Positive Phase 3 Peanut Patch Data
3M ago
8K
DBVT
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
5M ago
AAL
AMD
DBV Technologies Stock (DBVT) Soars as Clinical Trial Results Trigger Analyst Price Target Increases
Premium
Market News
DBV Technologies Stock (DBVT) Soars as Clinical Trial Results Trigger Analyst Price Target Increases
5M ago
DBVT
Optimistic Buy Recommendation for DBV Technologies Driven by Viaskin Peanut’s Strong Clinical Results and Market Potential
Premium
Ratings
Optimistic Buy Recommendation for DBV Technologies Driven by Viaskin Peanut’s Strong Clinical Results and Market Potential
5M ago
DBVT
More DBVT News >

DBVT News on the Web

DBV Technologies Announces June 2026 General Meeting Amid Focus on Food Allergy Innovation
Market Chameleon
Neutral
Kepler Capital Sticks to Their Buy Rating for DBV Technologies (0QAJ)
TipRanks News
Bullish
Guggenheim Sticks to Its Buy Rating for DBV Technologies SA – American (DBVT)
TipRanks News
Bullish
Cantor Fitzgerald Sticks to Its Buy Rating for DBV Technologies SA – American (DBVT)
TipRanks News
Bullish
DBV Technologies Maintained at Buy as Commercialization Prospects Grow; $40 Price Target Reaffirmed
TipRanks News
Bullish
DBV Technologies price target raised to $55 from $47 at Citizens
TipRanks News
Bullish
DBV Technologies Bolsters Cash Position and Advances Peanut Allergy Program Toward Key Regulatory Milestones
Market Chameleon
Neutral
DBVT SWOT Analysis: Financial Challenges and Growth Potential Revealed in 10-Q Filing
GuruFocus News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
DBVT
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.5 articles
News Sentiment
This Week59%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DBVT’s Media Buzz Sentiment?
1 articles about DBVT were published this week. In an average week, 2.5 articles are published.
    What is DBVT’s weekly average amount of articles?
    In an average week, 2.5 articles about DBVT are published.
      What is DBVT’s News Sentiment?
      59% of articles about DBVT were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        AQSTAquestive Therapeutics
        GOSSGossamer Bio
        HTFLHeartFlow, Inc.
        Showing the stocks with the most bullish news sentiment over the past week